Are you ready for Congress’ “Wealth Transfer Act”?
The mainstream media will NOT cover this story… But luckily Teeka Tiwari is revealing all the details of this terrifying new bill that’s working its way through Congress.

He’ll even give away the name and ticker of his #1 investment for this new trend.
Click here to see his #1 investment

EKF Insider Trading (EKF Diagnostics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £3,535,872.80

EKF Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at EKF Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

EKF Diagnostics Share Price & Price History

Current Price: GBX 81.20
Price Change: Price Decrease of -0.4 (-0.49%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for EKF up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
1,000X Bigger than Crypto? ($25 Gets You In) 
LIVE ON CAMERA: The man who called #1 tech stocks of 2016, 2018, 2019 & 2020 based on return...

Reveals the details of a new tech set to grow:
113X bigger than the Internet...
600X bigger than 5G...
2,000X BIGGER than Bitcoin.

"This is the biggest investing moment in 400 years — and just $25 gets you in."

Brown believes the rollout could be days away...
Watch Jeff’s presentation HERE before it’s too late.
pixel

EKF Diagnostics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2021Adam ReynoldsInsiderSell500,000GBX 73£365,000
4/20/2021Christopher H B MillsInsiderSell3,963,591GBX 80£3,170,872.80
5/24/2019Adam ReynoldsInsiderSell400,000GBX 33£132,000
11/20/2018Christopher H B MillsInsiderSell491,493GBX 27£132,703.11
11/9/2018Adam ReynoldsInsiderSell1,250,000GBX 27£337,500
See Full Table
Insider Selling at EKF Diagnostics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for EKF Diagnostics and related companies.

SEC Filings (Institutional Ownership Changes) for EKF Diagnostics (LON:EKF)

EKF Diagnostics logo
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, and Africa. It offers DiaSpect and DiaSpect T hemoglobin analyzers; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes in a point-of-care setting; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers' milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, the company offers Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; sTNFRr1, a predictive marker of end stage renal disease; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; and RaPET Serology immunoassay kits, as well as reagents, calibrators, standards, and controls. Additionally, it provides contract manufacturing services, as well as services and distributes third party company's products. It sells its products directly to hospitals, laboratories, and government agencies, as well as through a network of distributors. EKF Diagnostics Holdings plc was founded in 1990 and is headquartered in Cardiff, the United Kingdom.
Read More on EKF Diagnostics

Today's Range

Now: GBX 81.20
Low: 80.40
High: 84.20

50 Day Range

MA: GBX 78.44
Low: 71
High: 84.10

52 Week Range

Now: GBX 81.20
Low: 56.50
High: 95

Volume

304,704 shs

Average Volume

690,999 shs

Market Capitalization

£369.45 million

P/E Ratio

23.20

Dividend Yield

1.37%

Beta

N/A

Who are the company insiders with the largest holdings of EKF Diagnostics?

EKF Diagnostics' top insider investors include:
  1. Adam Reynolds (Insider)
  2. Christopher H B Mills (Insider)
The Hottest "Next Gen Crypto" in the World Right Now
Billion-Dollar Crypto Fund Sells Most of Its Bitcoin and Puts $380 Million Into a $2 Crypto.
Here's why…
pixel